Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Capital Leases (2019 - 2025)

Orthofix Medical's Capital Leases history spans 7 years, with the latest figure at $17.1 million for Q4 2025.

  • For the quarter ending Q4 2025, Capital Leases fell 4.35% year-over-year to $17.1 million, compared with a TTM value of $17.1 million through Dec 2025, down 4.35%, and an annual FY2025 reading of $17.1 million, down 4.35% over the prior year.
  • Capital Leases for Q4 2025 was $17.1 million at Orthofix Medical, down from $17.2 million in the prior quarter.
  • The five-year high for Capital Leases was $20.3 million in Q1 2021, with the low at $17.1 million in Q4 2025.
  • Average Capital Leases over 5 years is $18.8 million, with a median of $18.8 million recorded in 2023.
  • Year-over-year, Capital Leases decreased 10.96% in 2021 and then fell 2.73% in 2022.
  • Tracing OFIX's Capital Leases over 5 years: stood at $19.9 million in 2021, then dropped by 3.27% to $19.2 million in 2022, then dropped by 3.67% to $18.5 million in 2023, then decreased by 3.76% to $17.8 million in 2024, then decreased by 4.35% to $17.1 million in 2025.
  • Per Business Quant, the three most recent readings for OFIX's Capital Leases are $17.1 million (Q4 2025), $17.2 million (Q3 2025), and $17.4 million (Q2 2025).